Company Email Format Management

Inversago Pharma

Biotechnology Research Ca 9 employees

Employees: 9
Contacts: 1
Emails: 1
Phones: 1

inversago.com LinkedIn

Inversago Pharma Overview

Headquarters: Ca
Website: inversago.com
Industry: Biotechnology Research
Employees: 9
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

CB1 Receptor Metabolic Disorders Diabetes NASH Pulmonary Fibrosis Obesity Diabetic Kidney Disease Diabetic Nephropathy

About Inversago Pharma

Located in Montreal, Inversago Pharma is a privately-owned Canadian biotech company at clinical-stage, specialized in the development of new therapies focusing on CB1 blockade, based on first-in-class, peripherally-acting, CB1 inverse agonists. The Company aims to provide new treatment options that improve the lives of patients affected by metabolic conditions such as Diabetic Kidney Disease (DKD), including Diabetic Nephropathy, Type 1 and Type 2 Diabetes (T1D / T2D), Non-Alcoholic Steatohepatitis (NASH), complications of obesity, hypertriglyceridemia (HTG), as well as fibrotic indications such as Progressive Fibrosis – Interstitial Lung Disease (PF-ILD), including Idiopathic Pulmonary Fibrosis (IPF).

Inversago Pharma Contact Details

People in AeroLeads: 3
With contact data: 1
Email contacts: 1; 33.3% coverage
Phone contacts: 1; 33.3% coverage

Inversago Pharma Org Chart

Sample employees and titles

Name	Title	Location	Contact
Jamie Stiff	Healthcare Venture Capital Investor	Toronto, Ontario, Canada	Email Phone
Sabina Bangash	Associate Director - Expertise	Greater Montreal Metropolitan Area, Canada	View
Karine Lalonde	Strategic & Entrepreneurial VP		View